gip and glp 1 hormones ​"Triple-Hormone" Drug Shows Record Weight Loss: At the American Diabetes Association's 2026 Scientific Sessions, researchers unveiled phase 3 trial results for retatrutide, the first therapy to glp 1 and gip agonist

Waldron et al

Temperature also plays a role: warm skin brings vessels closer to the surface

: #PeptideTherapeutics #Biopharma #DrugDiscovery #PharmaceuticalInnovation #PeptideDrugs #TargetedTherapies #Biotechnology #HealthcareInnovation #OncologyResearch #Immunotherapy #ChronicDiseaseTreatment #PeptideBasedMedicine To view or add a comment, sign in Potent peptide ligands for therapeutically relevant targets are regularly returned from screening trillion-member libraries of ribosomally synthesized peptides containing non-canonical amino acids and macrocyclic architectures

In overall analysis, genetic associations with type 2 diabetes were obtained from DIAGRAM [32] (Additional file 1: Table S1)